Why Cannabis Is A Medication That’s Worth Legalizing

Why Cannabis Infographic

Chronic pain is a large problem.  Not only does 1/3 America suffer from it, but because the pain is both subjective and personal, it has been very difficult to treat. In fact, until the 1990s, it went largely under treated until opioid prescriptions began to rapidly increase. Today, we have an epidemic. But, while marijuana Read the full article…

Massachusetts: Medical Marijuana Patients Afforded Workplace Protections

Massachusetts: Medical Marijuana Patients Afforded Workplace Protections

MASSACHUSETTS: State-registered medical cannabis patients may sue a private employer for discrimination if they are fired for their off-the-job marijuana use, according to a first in the nation ruling issued Monday by the Massachusetts Supreme Judicial Court. Opining for the court, Chief Justice Ralph Gants determined that it is “not facially unreasonable” for employers to make exceptions to Read the full article…

Sales Of Legal Cannabis Products Expected To Accelerate

Sales of legal cannabis predicted to continue growth

NEW YORK: Medical cannabis sales are forecast to grow to $5.3 billion in 2017 and accounting for 67% of total cannabis sales, according to a new research report published by New Frontier Data.  By 2025, medical sales in currently legal states are forecast to grow to $13.2 billion, at which point medical sales will account for 55% of all Read the full article…

PA Marijuana Dispensary Agent Training Class In Pittsburgh Sunday, June 25th

medical  cannabis job training in PA

PENNSYLVANIA: HempStaff, a medical marijuana staffing and training agency, is hosting a Medical Marijuana Dispensary Agent Training Class in Pittsburgh, Pennsylvania on Sunday, June 25, 2017. The class will be held at the Embassy Suites Pittsburgh, located at 550 Cherrington Parkway, Coraopolis, Pennsylvania. There are 2 sessions to choose from: 8:00 a.m.-12:00 p.m. or 1:30 p.m.-5:30 p.m. The cost is $249 with prior online registration or $300 (cash-only) at the door, Read the full article…

Tilray Announces Support For Clinical Trial Examining Cannabis And Chronic Lung Disease

Tilray clinical trials progress

CANADA: Tilray, a global leader in medical cannabis research and production, today announced a partnership with the Research Institute of the McGill University Health Centre (RI-MUHC) in Montreal, one of the world’s premier public academic and research institutions, to study the effects of vaporized cannabis on symptoms associated with chronic obstructive pulmonary disease (COPD). The Phase II trial will Read the full article…

Review Identifies 140 Controlled Clinical Trials Related to Cannabis

mmj

GERMANY: Scientists have conducted over 140 controlled clinical trials since 1975 assessing the safety and efficacy of either whole-plant cannabis or specific cannabinoids, according to a literature review published in the journal Critical Reviews in Plant Sciences. A pair of German researchers identified 140 clinical trials involving an estimated 8,000 participants. Of these, the largest body of literature focuses Read the full article…

Study: Maternal Cannabis Use Not Associated With Adverse Neurodevelopment

cannabis and maternal health

MARYLAND: Cannabis exposure in utero is not associated with any significant, long-lasting adverse outcomes in offspring, according to a scientific review published online ahead of print in the journal Preventive Medicine. A pair of researchers from the University of Maryland, Department of Obstetrics, Gynecology and Reproductive Sciences and the Virginia Commonwealth University, Department of Obstetrics and Gynecology and Psychiatry reviewed four Read the full article…

Study: Marijuana Use Linked To Lower Prevalence Of Fatty Liver Disease

"We observed a strong dose-dependent reduction in the prevalence of NAFLD with cannabis use suggesting that cannabis use might suppress or reverse NAFLD development."

MASSACHUSETTS: Subjects who consume cannabis are significantly less likely to suffer from non-alcoholic fatty liver disease (NAFLD) as compared to those who do not, according to population-based case-control data published in the journal PLOS One. Non-alcoholic fatty liver disease is the most prevalent form of liver disease in humans, affecting an estimated 80 to 100 million people in the United States. Read the full article…

Tilray Announces Medical Cannabis Export To Cyprus

Tilray to export mmj to Cyprus

CANADA:  Tilray, a global leader in medical cannabis research and production, today announced that Tilray cannabinoid products have arrived and are cleared for distribution in European Union member state Cyprus after the company received necessary approvals in Canada and Cyprus to export cannabinoid formulations for patients in Cyprus. “We are proud to be able to offer Read the full article…

Delaware Executes Cannabis Tracking Contract With BioTrackTHC

Delaware selects BioTrackTHC

DELAWARE: The State of Delaware Department of Health and Social Services (DHSS), the government agency responsible for regulating the medical use of cannabis in Delaware, has executed the state’s cannabis seed-to-sale tracking and patient registry contract with BioTrackTHC. Delaware’s stated goals for the Medical Marijuana Program include, “protect the people of Delaware by minimizing the risk of theft and Read the full article…